$OCGN filed an 8-K with results (Item 2.02) at 8:28 AM ET on Wed, Nov 4.
Vote
OCGN
Ocugen, Inc.$0.8200CS band Weak
+0.07 (+10.04%) At close · Today 11:54 AM ET
About OCGN
Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe. The company's pipeline includes Modifier Gene Therapy Platform, Novel Biologic Therapy for Retinal Diseases, Regenerative Medicine Cell Therapy Platform, Inhaled Mucosal Vaccine Platform. The company is developing a modifier gene therapy platform designed to fulfill unmet medical needs related to retinal diseases, including inherited retinal diseases ("IRDs"), such as RP, LCA, Stargardt disease, and multifactorial diseases such as dAMD and Geographic Atrophy ("GA").
Board
Community opinions, not advice. Posts with a target get a receipt. How receipts work ›